Opens in a new tab

Dr. Li Jing

Chinese name: 李靖
Chief Physician, Professor, Doctoral Supervisor . Allergy and Clinical Immunology
Dr. Li Jing is Director of the Department of Allergy and Clinical Immunology at the First Affiliated Hospital of Guangzhou Medical University. A leading specialist in allergic diseases, she has spent more than three decades studying house dust mite allergy and allergen immunotherapy, and leads multidisciplinary care for patients with asthma, allergic rhinitis and other allergic disorders.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

nearly 20 years
Allergy and clinical immunology experience
3 consensus documents
Expert consensus documents led in China
1 award
Chinese Medical Association High-Impact Respiratory Research Paper Award

  • The Physician

About Dr. Li Jing

Dr. Li Jing is Director of the Department of Allergy and Clinical Immunology at the First Affiliated Hospital of Guangzhou Medical University and a professor of respiratory medicine. She holds a master's degree in molecular immunology from McMaster University and is a distinguished professor at Loma Linda University in the United States. Her research focuses on the epidemiology, mechanisms and immunotherapy of allergic diseases, particularly house dust mite allergy, and she leads a multidisciplinary allergy clinic for difficult cases. She is recognised as a leading expert in allergen immunotherapy in China.
1、Director of the Department of Allergy and Clinical Immunology, First Affiliated Hospital of Guangzhou Medical University
2、Professor of Respiratory Medicine and doctoral supervisor
3、Adjunct professor at Loma Linda University, United States
4、Member of the Allergy Branch of the Chinese Medical Association
5、Member of the Asthma Group of the Chinese Thoracic Society
6、Awardee of the Guangdong Medical Leading Talent programme and the Guangzhou high-level talent programme
7、Principal investigator of studies on house dust mite immunotherapy for allergic asthma and rhinitis

Dr. Li Jing ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Allergic asthma

She diagnoses and treats allergic asthma with inhaled therapy and allergen-specific immunotherapy, using skin and specific IgE testing to identify triggers and tailoring treatment to each patient's sensitisation profile, improving symptom control and reducing the need for rescue medication over the long term.

Allergic rhinitis

She manages allergic rhinitis and rhinosinusitis with allergen avoidance, pharmacotherapy and subcutaneous or sublingual immunotherapy, coordinating with ear, nose and throat specialists, ophthalmologists and dermatologists to relieve nasal symptoms, improve sleep and control coexisting asthma in children, adults and older patients.

Allergen immunotherapy and mite allergy

She leads house dust mite specific immunotherapy for asthma and rhinitis, assessing clinical response and antibody changes, and works to make immunotherapy safer, more effective and more widely available to allergic patients across China in routine clinical practice and primary care.

More： food allergy——diagnosis and management; drug allergy——evaluation; urticaria——treatment; atopic dermatitis——management; eosinophilic airway disease——diagnosis

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. IgG4 response during house dust mite immunotherapy for allergic asthma
A clinical immunology study showing that allergen-specific IgG4 levels correlate with clinical responses during house dust mite immunotherapy in patients with allergic asthma, supporting the use of IgG4 as a useful biomarker for monitoring the effectiveness of allergy immunotherapy in treated patients.
2. Allergen immunotherapy-induced IgG4 reduces basophil activation in allergic asthma
A mechanistic study demonstrating that IgG4 antibodies induced by house dust mite immunotherapy reduce basophil activation in patients with allergic asthma, explaining how allergen immunotherapy suppresses allergic inflammation and improves symptom control in treated patients with allergic asthma and rhinitis over time.
3. Cross-reactive IgG4 after Dermatophagoides pteronyssinus immunotherapy
A clinical study showing that subcutaneous immunotherapy with Dermatophagoides pteronyssinus induces cross-reactive specific IgG4 that also recognises Dermatophagoides farinae, providing immunological evidence for broader protection against house dust mite allergy in treated patients with allergic rhinitis and asthma in southern China.
4. Rural environment reduces allergic inflammation by modulating the gut microbiota
A study investigating how growing up in a rural environment reshapes the gut microbiota and reduces allergic inflammation in children, revealing microbial mechanisms that may inform new strategies to prevent allergic asthma and allergic rhinitis in urban and rural populations.
5. Environmental and sensitization variations among asthma and rhinitis patients (2008-2018)
A decade-long analysis of environmental exposures and allergen sensitization patterns among patients with asthma and allergic rhinitis in China, showing how urbanization and changing living conditions altered sensitization profiles and informing allergy prevention, diagnosis and clinical treatment strategies in southern China.
6. Specific IgG4 correlates with Th2 cytokine reduction during mite immunotherapy
A clinical study showing that allergen immunotherapy for house dust mite allergy increases specific IgG4 that correlates with reduced Th2 cytokine levels, providing supportive evidence for the immunological mechanism and long-term efficacy of allergen immunotherapy in allergic asthma patients during clinical care.
  • Affiliated Hospital

Where Dr. Li Jing practices

Guangzhou

The First Affiliated Hospital of Guangzhou Medical University

Chinese name: 广州医科大学附属第一医院
Guangzhou Medical University First Affiliated Hospital, founded in 1903 and led by respiratory scientist Academician Zhong Nanshan, hosts the National Respiratory Medical Center and a national key laboratory, offering 13 national key specialties across 2,850 beds as one of China's leading respiratory-care institutions.
Since 1903
123 years of care
2,850
Licensed beds
15
National-level platforms
Host institution
Licensed beds
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Li Jing?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Li Jing.